AUM$50.1M
Expense Ratio0.50%
NAV$45.74
Holdings49
InceptionApr 4, 2019
Price Chart
Key Statistics
Previous Close
$45.00Day Range
$43.66$44.69
52-Week Range
$27.88$49.76
Avg Volume
10.9KDividend Yield
1.29%Expense Ratio
0.50%AUM
$50.1MShares Outstanding
1.1MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.66% |
| Technology | 0.34% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 82.96% |
| Netherlands | 4.22% |
| Germany | 3.88% |
| Switzerland | 3.61% |
| United Kingdom | 2.33% |
| Singapore | 1.55% |
| China | 1.44% |
| Other | 0.02% |
Fund Information
- Issuer
- Global X
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Apr 4, 2019
- Exchange
- NASDAQ
- Description
- The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
Similar ETFs
The Global X - Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund issued by Global X that launched on Apr 4, 2019. It currently manages $50.1M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 49 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 49.9% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | MODERNA INC | 7.53% | 76,841 | $3.9M |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | 6.47% | 9,697 | $3.3M |
| 3 | ARWR | ARROWHEAD PHARMACEUTICALS IN | 5.79% | 47,107 | $3.0M |
| 4 | GH | GUARDANT HEALTH INC | 4.83% | 26,261 | $2.5M |
| 5 | ILMN | ILLUMINA INC | 4.69% | 19,973 | $2.4M |
| 6 | BMRN | BIOMARIN PHARMACEUTICAL INC | 4.49% | 36,598 | $2.3M |
| 7 | VRTX | VERTEX PHARMACEUTICALS INC | 4.26% | 4,551 | $2.2M |
| 8 | NTRA | NATERA INC | 4.01% | 9,843 | $2.1M |
| 9 | BNTX | BIONTECH SE-ADR | 3.93% | 18,367 | $2.0M |
| 10 | RNA | AVIDITY BIOSCIENCES INC | 3.87% | 27,249 | $2.0M |
| 11 | QGEN | QIAGEN N.V. | 3.53% | 38,211 | $1.8M |
| 12 | TECH | BIO-TECHNE CORP | 3.26% | 30,603 | $1.7M |
| 13 | CRSP | CRISPR THERAPEUTICS AG | 3.19% | 30,338 | $1.6M |
| 14 | BMY | BRISTOL-MYERS SQUIBB CO | 2.66% | 22,278 | $1.4M |
| 15 | ALNY | ALNYLAM PHARMACEUTICALS INC | 2.53% | 3,941 | $1.3M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -2.38% | — | ||
| 1W | -4.39% | — | ||
| 1M | -2.89% | — | ||
| 3M | -3.81% | — | ||
| 6M | +23.93% | — | ||
| YTD | -1.46% | — | ||
| 1Y | +25.49% | — | ||
| 3Y | -7.33% | — | ||
| 5Y | -53.22% | — |
Moving Averages
20-Day MA
$46.42
Below 20-Day MA50-Day MA
$47.05
Below 50-Day MA200-Day MA
$39.85
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$49.76
Current Price
$43.93
52-Week Low
$27.88
$27.88$49.76
Current Yield
1.29%
Annual Dividend
$0.6384
Frequency
2x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.5912 | Jan 7, 2026 |
| Jun 27, 2025 | $0.0083 | Jul 7, 2025 |
| Dec 30, 2021 | $0.0065 | Jan 7, 2022 |
| Dec 30, 2020 | $0.0324 | Jan 8, 2021 |
Dividend Payments Over Time
Category Comparison
| Metric | GNOM | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.50% | 0.60% | 0.84% |
| AUM | $50.1M | $1.25B | $1.62B |
| Dividend Yield | 1.29% | 2.75% | 14.38% |
| Avg Volume | 10.9K | 769.9K | 1.3M |
| Holdings | 49 | 182 | 67 |
| Performance | |||
| 1-Month Return | — | -3.02% | -2.05% |
| 6-Month Return | +20.68% | +5.85% | +15.05% |
| YTD Return | -1.00% | +0.17% | +1.05% |
| 1-Year Return | +28.28% | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with GNOM: